Development of Dendritic Cell-Based Immunotherapy for Autoimmunity

REFERENCES

• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.
   PubMed Web of Science ®Google Scholar
• Ohnmacht C, Pullner A, King SB, . Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206: 549–559.
   PubMed Web of Science ®Google Scholar
• Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151–161.
   PubMed Web of Science ®Google Scholar
• Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007; 7: 543–555.
   PubMed Web of Science ®Google Scholar
• Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219–1226.
   PubMed Web of Science ®Google Scholar
• Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 2001; 14: 495–498.
   PubMed Web of Science ®Google Scholar
• Liu YJ. A unified theory of central tolerance in the thymus. Trends Immunol 2006; 27: 215–221.
   Google Scholar
• Manickasingham A, Reis e Sousa C. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J Immunol 2000; 165: 5027–5034.
   PubMed Web of Science ®Google Scholar
• Itano AA, McSorley SJ, Reinhardt RL, . Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003; 19: 47–57.
   PubMed Web of Science ®Google Scholar
• Allan RS, Waithman J, Bedoui S, . Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25: 153–162.
   PubMed Web of Science ®Google Scholar
• Merad M, Ginhoux F. Dendritic cell genealogy: A new stem or just another branch? Nat Immunol 2007; 8: 1199–1201.
   Google Scholar
• Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7: 19–30.
   PubMed Web of Science ®Google Scholar
• Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol Today 1999; 20: 561–567.
   PubMedGoogle Scholar
• Macatonia SE, Hosken NA, Litton M, . Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995; 154: 5071–5079.
   PubMed Web of Science ®Google Scholar
• Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 1997; 90: 1920–1926.
   PubMed Web of Science ®Google Scholar
• Probst HC, Lagnel J, Kollias G, Van Den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 2003; 18: 713–720.
   PubMed Web of Science ®Google Scholar
• Tarbell KV, Yamazaki S, Olson K, . CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467–1477.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Wang YH, Lee HK, . Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181–1185.
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Patel M, Harper A, . Effective expansion of alloantigen-specific Foxp3 +CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A 2006; 103: 2758–2763.
   PubMed Web of Science ®Google Scholar
• McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195: 221–231.
   PubMed Web of Science ®Google Scholar
• Van Der Kleij D, Latz E, Brouwers JF, . A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122–48129.
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Jonuleit H, Muller G, . Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999; 93: 1634–1642.
   PubMed Web of Science ®Google Scholar
• Sato K, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003; 18: 367–379.
   PubMed Web of Science ®Google Scholar
• Lan YY, Wang Z, Raimondi G, . “Alternatively activated” dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 2006; 177: 5868–5877.
   PubMed Web of Science ®Google Scholar
• Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002; 73: S19--S22.
   Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685–711.
   PubMed Web of Science ®Google Scholar
• Kubach J, Becker C, Schmitt E, . Dendritic cells: Sentinels of immunity and tolerance. Int J Hematol 2005; 81: 197–203.
   PubMed Web of Science ®Google Scholar
• Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610–621.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Schuler G, . Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213–1222.
   PubMed Web of Science ®Google Scholar
• Levings MK, Gregori S, Tresoldi E, . Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005; 105: 1162–1169.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Steinman RM, Krasovsky J, . Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233–238.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100: 174–177.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–787.
   PubMed Web of Science ®Google Scholar
• Shevach EM. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 2006; 25: 195–201.
   PubMed Web of Science ®Google Scholar
• Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, . A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204: 1757–1764.
   PubMed Web of Science ®Google Scholar
• Sun CM, Hall JA, Blank RB, . Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775–1785.
   PubMed Web of Science ®Google Scholar
• Birnberg T, L. Bar-On, Sapoznikov A, . Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 2008; 29: 986–997.
   PubMed Web of Science ®Google Scholar
• Goubier A, Dubois B, Gheit H, . Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008; 29: 464–475.
   PubMedGoogle Scholar
• de HJ Heer, Hammad H, Soullie T, . Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200: 89–98.
   Google Scholar
• Bjorck P, Coates PT, Wang Z, . Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody. J Heart Lung Transplant 2005; 24: 1118–1120.
   Google Scholar
• Ochando JC, Homma C, Yang Y, . Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652–662.
   PubMed Web of Science ®Google Scholar
• Jongbloed SL, Benson RA, Nickdel MB, . Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol 2009; 182: 963–968.
   Web of Science ®Google Scholar
• Chen M, Wang YH, Wang Y, . Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006; 311: 1160–1164.
   PubMed Web of Science ®Google Scholar
• Jung S, Unutmaz D, Wong P, . In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211–220.
   PubMed Web of Science ®Google Scholar
• Whartenby KA, Calabresi PA, McCadden E, . Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc Natl Acad Sci U S A 2005; 102: 16741–16746.
   PubMed Web of Science ®Google Scholar
• Zvaifler NJ, Steinman RM, Kaplan G, . Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest 1985; 76: 789–800.
   PubMed Web of Science ®Google Scholar
• van AC Dinther-Janssen, Pals ST, Scheper R, . Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J Rheumatol 1990; 17: 11–17.
   Google Scholar
• Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994; 152: 2613–2623.
   PubMed Web of Science ®Google Scholar
• Lande R, Giacomini E, Serafini B, . Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol 2004; 173: 2815–2824.
   PubMed Web of Science ®Google Scholar
• Jongbloed SL, Lebre MC, Fraser AR, . Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 2006; 8: R15.
   PubMed Web of Science ®Google Scholar
• Lebre MC, Jongbloed SL, Tas SW, . Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP-dendritic cells with distinct cytokine profiles. Am J Pathol 2008; 172: 940–950.
   PubMed Web of Science ®Google Scholar
• Takakubo Y, Takagi M, Maeda K, . Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis. J Rheumatol 2008; 35: 1919–1931.
   PubMed Web of Science ®Google Scholar
• van Blokland SC, Wierenga-Wolf AF. van Helden-Meeuwsen CG, et al. Professional antigen presenting cells in minor salivary glands in Sjogren's syndrome: Potential contribution to the histopathological diagnosis? Lab Invest 2000; 80: 1935–1941.
   Google Scholar
• Gottenberg JE, Cagnard N, Lucchesi C, . Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 2006; 103: 2770–2775.
   PubMed Web of Science ®Google Scholar
• Wildenberg ME, Welzen-Coppens JM, van Helden-Meeuwsen CG, . Increased frequency of CD16 +monocytes and the presence of activated dendritic cells in salivary glands in primary Sjogren syndrome. Ann Rheum Dis 2009; 68: 420–426.
   PubMed Web of Science ®Google Scholar
• Lutzky V, Hannawi S, Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther 2007; 9: 219.
   Google Scholar
• Dittel BN, Visintin I, Merchant RM, Janeway CA, Jr. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol 1999; 163: 32–39.
   Google Scholar
• Ludewig B, Ochsenbein AF, Odermatt B, . Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med 2000; 191: 795–804.
   PubMed Web of Science ®Google Scholar
• Leung BP, Conacher M, Hunter D, . A novel dendritic cell-induced model of erosive inflammatory arthritis: Distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol 2002; 169: 7071–7077.
   PubMedGoogle Scholar
• Eriksson U, Ricci R, Hunziker L, . Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003; 9: 1484–1490.
   PubMed Web of Science ®Google Scholar
• Martin DA, Zhang K, Kenkel J, . Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling. J Immunol 2007; 179: 5819–5828.
   Google Scholar
• Klareskog L, Forsum U, Scheynius A, . Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 1982; 79: 3632–3636.
   PubMed Web of Science ®Google Scholar
• Pettit AR, MacDonald KP, B. O'sullivan, Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum 2000; 43: 791–800.
   PubMedGoogle Scholar
• Young LJ, Wilson NS, Schnorrer P, . Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol 2008; 9: 1244–1252.
   PubMed Web of Science ®Google Scholar
• Ludewig B, Odermatt B, Landmann S, . Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998; 188: 1493–1501.
   PubMed Web of Science ®Google Scholar
• Radstake TR, Van Der Voort R, ten Brummelhuis M, . Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann Rheum Dis 2005; 64: 359–367.
   PubMed Web of Science ®Google Scholar
• Hjelmstrom P. Lymphoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001; 69: 331–339.
   PubMed Web of Science ®Google Scholar
• Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999; 10: 27–39.
   PubMed Web of Science ®Google Scholar
• Lakey RL, Morgan TG, Rowan AD, . A novel paradigm for dendritic cells as effectors of cartilage destruction. Rheumatology (Oxford) 2009; 48: 502–507.
   Google Scholar
• Dahlen E, Dawe K, Ohlsson L, Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 1998; 160: 3585–3593.
   PubMed Web of Science ®Google Scholar
• Moghaddami M, Cleland LG, Radisic G, Mayrhofer G. Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation. Arthritis Res Ther 2007; 9: R120.
   Google Scholar
• Bobryshev YV. Dendritic cells in atherosclerosis: Current status of the problem and clinical relevance. Eur Heart J 2005; 26: 1700–1704.
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 2005; 7: 1–24.
   PubMedGoogle Scholar
• Yilmaz A, Lochno M, Traeg F, . Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004; 176: 101–110.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419–426.
   PubMed Web of Science ®Google Scholar
• Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 67 Suppl 3: iii, 90–96, 2008.
   Google Scholar
• Morita Y, Yang J, Gupta R, . Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 2001; 107: 1275–1284.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim S, Evans CH, . Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol 2001; 166: 3499–3505.
   PubMed Web of Science ®Google Scholar
• Kaneko K, Wang Z, Kim SH, . Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection. Gene Ther 2003; 10: 143–152.
   PubMedGoogle Scholar
• Coates PT, Krishnan R, Kireta S, . Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice. Gene Ther 2001; 8: 1224–1233.
   PubMed Web of Science ®Google Scholar
• Lu L, Gambotto A, Lee WC, . Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther 1999; 6: 554–563.
   PubMed Web of Science ®Google Scholar
• Tan PH, Yates JB, Xue SA, . Creation of tolerogenic human dendritic cells via intracellular CTLA4: A novel strategy with potential in clinical immunosuppression. Blood 2005; 106: 2936–2943.
   PubMed Web of Science ®Google Scholar
• Yang DF, Qiu WH, Zhu HF, . CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice. Transpl Immunol 2008; 19: 197–201.
   PubMed Web of Science ®Google Scholar
• Min WP, Gorczynski R, Huang XY, . Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000; 164: 161–167.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim S, Oligino TJ, Robbins PD, Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL. Mol Ther 2002; 6: 584–590.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xu X, Hsu HC, . CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 2003; 112: 1332–1341.
   PubMed Web of Science ®Google Scholar
• Hill JA, Ichim TE, Kusznieruk KP, Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 2003; 171: 691–696.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen T, Wang HQ, . Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells. Transplant Proc 2006; 38: 1561–1563.
   Google Scholar
• Liang X, Lu L, Chen Z, . Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003; 76: 721–729.
   PubMed Web of Science ®Google Scholar
• Xiang J, Gu X, Zhou Y, . Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival. Microsurgery 2007; 27: 320–323.
   Google Scholar
• Zheng X, Vladau C, Zhang X, . A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009; 113: 2646–2654.
   PubMedGoogle Scholar
• Machen J, Harnaha J, Lakomy R, . Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004; 173: 4331–4341.
   PubMed Web of Science ®Google Scholar
• Martin E, O'Sullivan B, Low P, Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003; 18: 155–167.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang X, Zheng X, . Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 2007; 178: 5480–5487.
   PubMed Web of Science ®Google Scholar
• Giannoukakis N, Bonham CA, Qian S, . Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000; 1: 430–437.
   PubMed Web of Science ®Google Scholar
• Bonham CA, Peng L, Liang X, . Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol 2002; 169: 3382–3391.
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Graulich E, Kubsch S, . CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002; 99: 2468–2476.
   PubMed Web of Science ®Google Scholar
• Yarilin D, Duan R, Huang YM, Xiao BG. Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis. Clin Exp Immunol 2002; 127: 214–219.
   PubMed Web of Science ®Google Scholar
• Wakkach A, Fournier N, Brun V, . Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605–617.
   PubMed Web of Science ®Google Scholar
• Koya T, Matsuda H, Takeda K, . IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J Allergy Clin Immunol 2007; 119: 1241–1250.
   PubMed Web of Science ®Google Scholar
• H. Hackstein, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24–34.
   PubMed Web of Science ®Google Scholar
• L. Adorini, Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol, 2009; 251–273.
   Google Scholar
• van Kooten C, Stax AS, Woltman AM, Gelderman KA. Handbook of experimental pharmacology “dendritic cells”: The use of dexamethasone in the induction of tolerogenic DCs. Handb Exp Pharmacol, 2009: 233–249.
   Google Scholar
• Fischer R, Turnquist HR, Taner T, Thomson AW. Use of rapamycin in the induction of tolerogenic dendritic cells. Handb Exp Pharmacol, 2009: 215–232.
   PubMedGoogle Scholar
• Xia CQ, Peng R, Beato F, Clare-Salzler MJ. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 2005; 62: 45–54.
   Google Scholar
• Penna G, Adorini L. 1Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405–2411.
   PubMed Web of Science ®Google Scholar
• Turnquist HR, Raimondi G, Zahorchak AF, . Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3 +T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178: 7018–7031.
   PubMed Web of Science ®Google Scholar
• Anderson AE, Sayers BL, Haniffa MA, . Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008; 84: 124–133.
   PubMed Web of Science ®Google Scholar
• Anderson AE, Swan DJ, Sayers BL, . LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukoc Biol 2009; 85: 243–250.
   PubMed Web of Science ®Google Scholar
• Xing N, Maldonado ML, Bachman LA, . Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 2002; 297: 645–652.
   PubMedGoogle Scholar
• Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9: 324–337.
   PubMed Web of Science ®Google Scholar
• Jhunjhunwala S, Raimondi G, Thomson AW, Little SR. Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release 2009; 133: 191–197.
   PubMed Web of Science ®Google Scholar
• Dong X, Bachman LA, Kumar R, Griffin MD. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl Immunol 2003; 11: 323–333.
   PubMed Web of Science ®Google Scholar
• Pedersen AE, Gad M, Walter MR, Claesson MH. Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3). Immunol Lett 2004; 91: 63–69.
   PubMedGoogle Scholar
• Xystrakis E, Kusumakar S, Boswell S, . Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116: 146–155.
   PubMed Web of Science ®Google Scholar
• Pierce JW, Schoenleber R, Jesmok G, . Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096–21103.
   PubMed Web of Science ®Google Scholar
• Martin E, Capini C, Duggan E, Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB. Arthritis Rheum 2007; 56: 2255–2266.
   PubMedGoogle Scholar
• Steinbrink K, Wolfl M, Jonuleit H, . Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772–4780.
   PubMed Web of Science ®Google Scholar
• Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 2000; 30: 1233–1242.
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Allavena P, . Glucocorticoids increase the endocytic activity of human dendritic cells. Int Immunol 1999; 11: 1519–1526.
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Allavena P, . Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162: 6473–6481.
   PubMed Web of Science ®Google Scholar
• Woltman AM, de Fijter JW, Kamerling SW, . The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30: 1807–1812.
   PubMed Web of Science ®Google Scholar
• Garrod KR, Chang CK, Liu FC, . Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. J Immunol 2006; 177: 863–868.
   PubMedGoogle Scholar
• Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: Balancing immunity and tolerance. Nat Rev Immunol 2008; 8: 362–371.
   PubMed Web of Science ®Google Scholar
• Taner T, Hackstein H, Wang Z, . Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 2005; 5: 228–236.
   PubMed Web of Science ®Google Scholar
• Sordi V, Bianchi G, Buracchi C, . Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: Selective upregulation by rapamycin. Transplantation 2006; 82: 826–834.
   PubMed Web of Science ®Google Scholar
• Reichardt W, Durr C, D. von Elverfeldt, . Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J Immunol 2008; 181: 4770–4779.
   PubMed Web of Science ®Google Scholar
• Pan J, Ju D, Wang Q, . Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001; 76: 153–161.
   PubMed Web of Science ®Google Scholar
• Menges M, Rossner S, Voigtlander C, . Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002; 195: 15–21.
   PubMed Web of Science ®Google Scholar
• Kleindienst P, Wiethe C, Lutz MB, Brocker T. Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells. J Immunol 2005; 174: 3941–3947.
   Google Scholar
• Voigtlander C, Rossner S, Cierpka E, . Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J Immunother 2006; 29: 407–415.
   Google Scholar
• Salazar L, Aravena O, Abello P, . Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells. Ann Rheum Dis 2008; 67: 1235–1241.
   PubMedGoogle Scholar
• Tacken PJ, Torensma R, Figdor CG. Targeting antigens to dendritic cells in vivo. Immunobiology 2006; 211: 599–608.
   PubMed Web of Science ®Google Scholar
• Hawiger D, Inaba K, Dorsett Y, . Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769–779.
   PubMed Web of Science ®Google Scholar
• Mahnke K, Guo M, Lee S, . The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000; 151: 673–684.
   PubMed Web of Science ®Google Scholar
• Mukhopadhaya A, Hanafusa T, Jarchum I, . Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc Natl Acad Sci U S A 2008; 105: 6374–6379.
   PubMed Web of Science ®Google Scholar
• Capini C, Jaturanpinyo M, Chang HI, . Antigen-specific suppression of inflammatory arthritis using liposomes. J Immunol 2009; 182: 3556–3565.
   PubMed Web of Science ®Google Scholar
• Andreakos E, Rauchhaus U, Stavropoulos A, . Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Arthritis Rheum 2009; 60: 994–1005.
   PubMed Web of Science ®Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, . Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380–386.
   PubMed Web of Science ®Google Scholar
• Baldridge JR, McGowan P, Evans JT, . Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 2004; 4: 1129–1138.
   PubMed Web of Science ®Google Scholar
• Res PC, Struijk L, Leow A, . Inflamed joints of patients with rheumatoid arthritis contain T cells that display in vitro proliferation to antigens present in autologous synovial fluid. Functional analysis on the basis of synovial-fluid-reactive T-cell clones and lines. Hum Immunol 1994; 40: 291–298.
   PubMed Web of Science ®Google Scholar
• Tsark EC, Wang W, Teng YC, . Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. J Immunol 2002; 169: 6625–6633.
   PubMed Web of Science ®Google Scholar
• Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999; 5: 900–906.
   PubMed Web of Science ®Google Scholar
• Turka LA, Lechler RI. Towards the identification of biomarkers of transplantation tolerance. Nat Rev Immunol 2009; 9: 521–526.
   PubMed Web of Science ®Google Scholar
• Newell KA, Larsen CP. Tolerance assays: Measuring the unknown. Transplantation 2006; 81: 1503–1509.
   Google Scholar
• Morgan AW, Hale G, Rebello PR, . A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis. QJM 2008; 101: 299–306.
   Google Scholar
• Clare MJ-Salzler, Brooks J, Chai A, . Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90: 741–748.
   Google Scholar
• Shinomiya M, Fazle SM Akbar, Shinomiya H, Onji M. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1999; 117: 38–43.
   PubMed Web of Science ®Google Scholar
• Feili-Hariri M, Dong X, Alber SM, . Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999; 48: 2300–2308.
   PubMed Web of Science ®Google Scholar
• Ma L, Qian S, Liang X, . Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes 2003; 52: 1976–1985.
   PubMed Web of Science ®Google Scholar
• Creusot RJ, Yaghoubi SS, Kodama K, . Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 2008; 127: 176–187.
   PubMed Web of Science ®Google Scholar
• van Duivenvoorde LM, Louis-Plence P, Apparailly F, . Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum 2004; 50: 3354–3364.
   Google Scholar
• Chorny A, Gonzalez-Rey E, Fernandez-Martin A, . Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc Natl Acad Sci U S A 2005; 102: 13562–13567.
   PubMed Web of Science ®Google Scholar
• Charbonnier LM, van Duivenvoorde LM, Apparailly F, . Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J Immunol 2006; 177: 3806–3813.
   PubMed Web of Science ®Google Scholar
• Popov I, Li M, Zheng X, . Preventing autoimmune arthritis using antigen-specific immature dendritic cells: A novel tolerogenic vaccine. Arthritis Res Ther 2006; 8: R141.
   PubMed Web of Science ®Google Scholar
• van Duivenvoorde LM, Han WG, Bakker AM, . Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 2007; 179: 1506–1515.
   Google Scholar
• Healy LJ, Collins HL, Thompson SJ. Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol J 2008; 2: 71–80.
   PubMedGoogle Scholar
• Jaen O, Rulle S, Bessis N, . Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Immunology 2009; 126: 35–44.
   PubMed Web of Science ®Google Scholar
• Huang YM, Yang JS, Xu LY, . Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 2000; 122: 437–444.
   PubMed Web of Science ®Google Scholar
• Xiao BG, Wu XC, Yang JS, . Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis. Int Immunol 2004; 16: 13–22.
   PubMed Web of Science ®Google Scholar
• Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006; 177: 1679–1688.
   Google Scholar
• Iruretagoyena MI, Sepulveda SE, Lezana JP, . Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006; 318: 59–67.
   Google Scholar
• Pettersson A, Ciumas C, Chirsky V, . Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis. J Neuroimmunol 2004; 156: 58–65.
   PubMedGoogle Scholar
• Verginis P, Li HS, Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J Immunol 2005; 174: 7433–7439.
   PubMed Web of Science ®Google Scholar
• Duan RS, Adikari SB, Huang YM, . Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Neurobiol Dis 2004; 16: 461–467.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang H, Xiao B, . Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Mol Immunol 2009; 46: 657–667.
   Google Scholar
• Jiang HR, Muckersie E, Robertson M, Forrester JV. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Invest Ophthalmol Vis Sci 2003; 44: 1598–1607.
   PubMed Web of Science ®Google Scholar
• Lau AW, Biester S, Cornall RJ, Forrester JV. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J Immunol 2008; 180: 3889–3899.
   PubMedGoogle Scholar
• Usui Y, Takeuchi M, Hattori T, . Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice. Arch Ophthalmol 2009; 127: 514–519.
   PubMedGoogle Scholar